Noah Medical

Noah Medical is a private, commercial-stage medical device company pioneering robotic-assisted bronchoscopy for lung nodule biopsy. Its Galaxy System, featuring proprietary TiLT+ imaging technology, is designed to overcome CT-to-body divergence and provide real-time tool-in-lesion confirmation, aiming for higher diagnostic yield and procedural efficiency. Backed by experienced leadership from top medtech firms and supported by early clinical data showing high diagnostic accuracy, the company is targeting the significant lung cancer diagnostics market. Noah Medical appears to be in an early revenue generation phase, scaling its commercial efforts in the competitive robotic bronchoscopy space.

The Galaxy System robotic bronchoscopy platform with proprietary Tool-in-Lesion Tomography (TiLT+) Technology, which integrates C-arm fluoroscopy for real-time, intra-procedural confirmation of biopsy tool placement within a lung lesion to overcome CT-to-body divergence.

The robotic-assisted bronchoscopy market is highly competitive, dominated by large, established players like Intuitive Surgical (Ion) and Johnson & Johnson (via its Auris Health acquisition). Other competitors include Medtronic and Boston Scientific. Noah Medical's differentiation hinges on its real-time TiLT+ imaging for tool-in-lesion confirmation, aiming to offer superior targeting accuracy compared to navigation-only systems.